Second Sight Medical Products, Inc. (EYES) Financial Statements (2023 and Earlier)

Company Profile

Business Address 13170 TELFAIR AVE.
SYLMAR, CA 91342
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments70311481116
Cash and cash equivalents7031148110
Short-term investments      16
Receivables  01202
Inventory, net of allowances, customer advances and progress billings  13338
Inventory  13338
Other undisclosed current assets1101111
Total current assets:7141310131527
Noncurrent Assets
Operating lease, right-of-use asset0 2
Property, plant and equipment0011111
Deposits noncurrent assets      0
Other undisclosed noncurrent assets000000 
Total noncurrent assets:0031121
TOTAL ASSETS:7141711141728
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2266653
Accounts payable1011111
Accrued liabilities1123222
Employee-related liabilities103332 
Deferred revenue 00
Debt 20    
Deferred revenue and credits000
Contract with customer, liability0
Other undisclosed current liabilities1111115
Total current liabilities:2578768
Noncurrent Liabilities
Long-term debt and lease obligation0 2    
Operating lease, liability0 2
Other undisclosed noncurrent liabilities(0)      
Total noncurrent liabilities:0 2    
Total liabilities:3598768
Stockholders' equity
Stockholders' equity attributable to parent, including:68(1)7381120
Common stock348270264229202187166
Additional paid in capital49494944413127
Accumulated other comprehensive loss(0)(0)(1)(1)(1)(1)(1)
Accumulated deficit(329)(320)(305)(269)(234)(206)(173)
Receivable from shareholders or affiliates for issuance of capital stock      (0)
Warrants and rights outstanding     1,038 
Other undisclosed stockholders' equity attributable to parent    0(1,038)0
Total stockholders' equity:68(1)7381120
TOTAL LIABILITIES AND EQUITY:7141711141728

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues0037849
Revenue, net84 
Net investment income000000 
Cost of revenue(0)(1)(2)(5)(5)(10)(5)
Cost of goods and services sold(0)(1)(2)(5)(5)(10)(0)
Other undisclosed gross profit01   (0) 
Gross profit:01123(6)4
Operating expenses(9)(15)(35)(37)(31)(27)(24)
Operating loss:(9)(15)(34)(35)(29)(33)(20)
Nonoperating income
(Other Nonoperating income)
      0
Net loss:(9)(15)(34)(35)(29)(33)(20)
Other undisclosed net income attributable to parent0000000
Net loss available to common stockholders, diluted:(9)(15)(34)(35)(29)(33)(20)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(9)(15)(34)(35)(29)(33)(20)
Other comprehensive loss     (33)(20)
Comprehensive loss:(9)(15)(34)(35)(29)(66)(40)
Other undisclosed comprehensive income, net of tax, attributable to parent000003320
Comprehensive loss, net of tax, attributable to parent:(9)(15)(34)(35)(28)(33)(20)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: